RIA Advisory Group’s Journey Medical DERM Stock Holding History

RIA Advisory Group’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,767	Closed	-$277K	–	148
2023 Q4	$277K	Buy	+1,767	New	+$7.87K	0.12%	94

Other funds holding DERM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RIA Advisory Group's DERM Position: Q1 2024 in Review

RIA Advisory Group sold out of Journey Medical (DERM) in Q1 2024, closing a stake of 1,767 shares — an estimated $277K sold.

RIA Advisory Group first reported a position in DERM in Q4 2023 and held it in 1 quarter. The position peaked at $277K in Q4 2023. 33 funds tracked by Wall St. Rank hold DERM as of Q1 2024.

RIA Advisory Group reported no remaining Journey Medical position as of Q1 2024 after selling out during the quarter.
RIA Advisory Group sold 1,767 Journey Medical shares in Q1 2024, an estimated $277K.
RIA Advisory Group first reported a position in Journey Medical in Q4 2023 and held it in 1 quarter.
RIA Advisory Group's Journey Medical position peaked at $277K in Q4 2023.
33 funds tracked by Wall St. Rank held Journey Medical as of Q1 2024.

Based on RIA Advisory Group's 13F filing for Q1 2024, filed 3 May 2024.